share_log

Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $135

Benzinga ·  May 2 08:21

Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $144 to $135.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment